Therapeutic Antibody Design Benchmark 2026

Consolidated antibody-design benchmark covering developability, CDR diversity, paratope prediction, and experimental binding on 12 targets.

Composite
97.0
Experimental validation
Wet-lab confirmed
Stages
Hit IDLead ID / ADMET
Modalities
biologic
Task types
binder-designdevelopabilityaffinity-prediction
Size
antibodies: 85,000
targets: 12
License
CC-BY-4.0
First release
2026-02
Last updated
2026-04
Official site
→ project page
Leaderboard
→ leaderboard
Dataset
→ dataset
Code / GitHub
→ repository
HuggingFace
→ HF
Paper
Benchmarking machine-learning antibody design 2026 · Ruffolo JA, Chung LK, et al. · 2026 · paper · doi:10.1038/s41586-026-09876-1 · 65 citations
Flags
none
Experts
Groups
Genentech gRED (ML)
Hosted by
Polaris Hub
Related benchmarks
SAbDab, Observed Antibody Space (OAS), IgLM / AntiBERTa benchmarks

Rubric (7-criterion)

rigor
5
coverage
5
maintenance
5
adoption
4
quality
5
accessibility
5
industry_relevance
5

Notes

Top-ranked submissions had wet-lab binding measured (Kd + aggregation) by independent labs.

← Back to all benchmarks

Compare:
Open comparison →